Javascript must be enabled to continue!
Posterior retroperitoneoscopic adrenalectomy—Case series
View through CrossRef
ABSTRACT
Introduction:
Posterior retroperitoneoscopic adrenalectomy has advantages over transperitoneal technique. However many surgeons prefer the transperitoneal technique because they get a familiar and wider working space.
Material and methods:
A retrospective analysis of the first 10 patients submitted to posterior retroperitoneoscopic adrenalectomy was conducted. Data collected included: diagnosis, size, operation time, blood loss, conversion rate, morbidity and mortality, in-hospital length of stay. Compare our outcomes with worldwide bigger series, and take conclusions on the feasibility of the technique was the objective.
Results:
We included 2 pheochromocytomas, 1 giant cystic pheochromocytoma, 4 Conn's, 2 Cushing's, 1 non-functioning tumor with 4 cm. Mean operation time was 46,7 min for lesions ranging from 1,8 to 14 cm. Blood loss was negligible. One patient (10%) was converted to laparotomy because of a past clinical history of dorsal and lumbar trauma. No morbidity and no mortality. Mean hospital length of stay was 2,2 days.
Discussion:
Mean operation time found in bigger series published in worldwide literature is 40-105,6 min. Complication rate reported ranges from 0 to 14,4%. No mortality has been ever reported. Blood loss reported in other series is 10-50 ml. The data found in our study matches other studies data. Since the same surgeon who had never performed the technique before operated all patients, makes us believe the technique is safe and feasible.
Conclusion:
Posterior retroperitoneoscopic adrenalectomy has a small learning curve. It is technically safe and feasible. More patients will be collected to validate these results.
Highlights
Ovid Technologies (Wolters Kluwer Health)
Title: Posterior retroperitoneoscopic adrenalectomy—Case series
Description:
ABSTRACT
Introduction:
Posterior retroperitoneoscopic adrenalectomy has advantages over transperitoneal technique.
However many surgeons prefer the transperitoneal technique because they get a familiar and wider working space.
Material and methods:
A retrospective analysis of the first 10 patients submitted to posterior retroperitoneoscopic adrenalectomy was conducted.
Data collected included: diagnosis, size, operation time, blood loss, conversion rate, morbidity and mortality, in-hospital length of stay.
Compare our outcomes with worldwide bigger series, and take conclusions on the feasibility of the technique was the objective.
Results:
We included 2 pheochromocytomas, 1 giant cystic pheochromocytoma, 4 Conn's, 2 Cushing's, 1 non-functioning tumor with 4 cm.
Mean operation time was 46,7 min for lesions ranging from 1,8 to 14 cm.
Blood loss was negligible.
One patient (10%) was converted to laparotomy because of a past clinical history of dorsal and lumbar trauma.
No morbidity and no mortality.
Mean hospital length of stay was 2,2 days.
Discussion:
Mean operation time found in bigger series published in worldwide literature is 40-105,6 min.
Complication rate reported ranges from 0 to 14,4%.
No mortality has been ever reported.
Blood loss reported in other series is 10-50 ml.
The data found in our study matches other studies data.
Since the same surgeon who had never performed the technique before operated all patients, makes us believe the technique is safe and feasible.
Conclusion:
Posterior retroperitoneoscopic adrenalectomy has a small learning curve.
It is technically safe and feasible.
More patients will be collected to validate these results.
Highlights.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Robotic-Assisted Retroperitoneoscopic Adrenalectomy: Making a Good Procedure Even Better
Robotic-Assisted Retroperitoneoscopic Adrenalectomy: Making a Good Procedure Even Better
Posterior retroperitoneoscopic adrenalectomy (PRA) is a minimally invasive procedure offering several advantages over a transabdominal laparoscopic operation. The three-dimensional...
Adrenal giant cystic pheochromocytoma treated by posterior retroperitoneoscopic adrenalectomy
Adrenal giant cystic pheochromocytoma treated by posterior retroperitoneoscopic adrenalectomy
ABSTRACT
INTRODUCTION:
Giant cystic pheochromocytoma (>10 cm) is rare with only a few cases described in the literatur...
Retroperitoneoscopic partial adrenalectomy for small adrenal tumours (≤1 cm): the Ruijin clinical experience in 88 patients
Retroperitoneoscopic partial adrenalectomy for small adrenal tumours (≤1 cm): the Ruijin clinical experience in 88 patients
Study Type – Therapy (case series)
Level of Evidence 4
OBJECTIVE
To present our experience of retroper...
Robotic Versus Laparoscopic Adrenalectomy: Pluriannual Experience in a High-Volume Center Evaluating Indications and Results
Robotic Versus Laparoscopic Adrenalectomy: Pluriannual Experience in a High-Volume Center Evaluating Indications and Results
Background:
Robotic adrenalectomy offers several clinical benefits if compared with laparoscopic adrenalectomy; however, its superiority is still under debate. ...
Primary Adrenal Tumors in Bitches
Primary Adrenal Tumors in Bitches
Background: Adrenal tumors are rare in dogs, accounting for less than 2% of diagnosed neoplasms. They can be primary or metastatic, and are classified as adrenocortical or medullar...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
SAT-226 Lifestyle Modifications or Adrenalectomy? Pheochromocytoma Presenting with New Onset Diabetes Mellitus
SAT-226 Lifestyle Modifications or Adrenalectomy? Pheochromocytoma Presenting with New Onset Diabetes Mellitus
Abstract
Introduction
When clinicians think of pheochromocytomas, diabetes might not be the first thing that comes to mind. Pheochromocytomas elicit d...

